Federation des caisses Desjardins du Quebec’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-180
| Closed | -$3.65K | – | 2417 |
|
|
2022
Q4 | $3.65K | Hold |
180
| – | – | ﹤0.01% | 2092 |
|
|
2022
Q3 | $1.94K | Hold |
180
| – | – | ﹤0.01% | 2268 |
|
|
2022
Q2 | $2.16K | Hold |
180
| – | – | ﹤0.01% | 2295 |
|
|
2022
Q1 | $3.86K | Hold |
180
| – | – | ﹤0.01% | 2255 |
|
|
2021
Q4 | $6.05K | Hold |
180
| – | – | ﹤0.01% | 2153 |
|
|
2021
Q3 | $4.63K | Sell |
180
-400
| -69% | -$7.15K | ﹤0.01% | 2259 |
|
|
2021
Q2 | $7.75K | Sell |
580
-350
| -38% | -$4.33K | ﹤0.01% | 2120 |
|
|
2021
Q1 | $9.88K | Hold |
930
| – | – | ﹤0.01% | 2006 |
|
|
2020
Q4 | $7.47K | Hold |
930
| – | – | ﹤0.01% | 1975 |
|
|
2020
Q3 | $6.96K | Hold |
930
| – | – | ﹤0.01% | 1778 |
|
|
2020
Q2 | $8.4K | Hold |
930
| – | – | ﹤0.01% | 1687 |
|
|
2020
Q1 | $8.91K | Hold |
930
| – | – | ﹤0.01% | 1698 |
|
|
2019
Q4 | $13.4K | Hold |
930
| – | – | ﹤0.01% | 1830 |
|
|
2019
Q3 | $14K | Hold |
930
| – | – | ﹤0.01% | 1748 |
|
|
2019
Q2 | $12.3K | Hold |
930
| – | – | ﹤0.01% | 1804 |
|
|
2019
Q1 | $12.2K | Hold |
930
| – | – | ﹤0.01% | 1624 |
|
|
2018
Q4 | $13.4K | Hold |
930
| – | – | ﹤0.01% | 1563 |
|
|
2018
Q3 | $16.6K | Buy |
930
+350
| +60% | +$6.06K | ﹤0.01% | 1602 |
|
|
2018
Q2 | $8.35K | Hold |
580
| – | – | ﹤0.01% | 1795 |
|
|
2018
Q1 | $11.1K | Buy |
+580
| New | +$12.5K | ﹤0.01% | 1694 |
|
Federation des caisses Desjardins du Quebec's OPNT Position: Q1 2023 in Review
Federation des caisses Desjardins du Quebec sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q1 2023, closing a stake of 180 shares — an estimated $3.65K sold.
Federation des caisses Desjardins du Quebec first reported a position in OPNT in Q1 2018 and held it in 20 quarters. The position peaked at $16.6K in Q3 2018. 0 funds tracked by Wall St. Rank hold OPNT as of Q1 2023.
- Federation des caisses Desjardins du Quebec reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- Federation des caisses Desjardins du Quebec sold 180 Opiant Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $3.65K.
- Federation des caisses Desjardins du Quebec first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q1 2018 and held it in 20 quarters.
- Federation des caisses Desjardins du Quebec's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $16.6K in Q3 2018.
- 0 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q1 2023.
Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2023, filed 15 Aug 2024.